. | . | [nAChR] (pmol kg-1 wet tissue)* . | . | |
---|---|---|---|---|
mAb . | Specificity . | Brain . | Small intestine . | |
mAb 210 | α3, α5 | 177±7 | 140±30 | |
mAb 313 | α3 | 73±23 | 40±7 | |
mAb 299 | α4 | 254±53 | 5±3.6 | |
mAb 306 | α7 | 730±80 | 41±7 | |
mAb 295 | β2 | 775±35 | 66±6 | |
mAb 337 | β4 | 13±1 | 1±0.2 |
. | . | [nAChR] (pmol kg-1 wet tissue)* . | . | |
---|---|---|---|---|
mAb . | Specificity . | Brain . | Small intestine . | |
mAb 210 | α3, α5 | 177±7 | 140±30 | |
mAb 313 | α3 | 73±23 | 40±7 | |
mAb 299 | α4 | 254±53 | 5±3.6 | |
mAb 306 | α7 | 730±80 | 41±7 | |
mAb 295 | β2 | 775±35 | 66±6 | |
mAb 337 | β4 | 13±1 | 1±0.2 |
Expressed as either [3H]epibatidine binding sites forα3-nAChRs ± s.d. (N=3) or[125I]αBgT binding sites for α7-nAChRs ± s.d. (N=3).